REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 6th, 2023 • NanoString Technologies Inc • Biological products, (no disgnostic substances)
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of November [_________], 2023, by and among NanoString Technologies, Inc., a Delaware corporation (the “Company”), and each of the Investors from time to time signatory hereto.
NANOSTRING TECHNOLOGIES, INC., THE GUARANTORS PARTY HERETO FROM TIME TO TIME, AND U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee and Collateral Agent INDENTURE Dated as of November [__], 2023 6.95% Senior Secured Notes due 2026NanoString Technologies Inc • November 6th, 2023 • Biological products, (no disgnostic substances) • New York
INDENTURE, dated as of [__________], 2023 among NanoString Technologies, Inc., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01), the Guarantors party hereto from time to time, and U.S. Bank Trust Company, National Association, a national banking association organized and existing under the laws of the United States of America, as trustee (in such capacity, the “Trustee,” as more fully set forth in Section 1.01) and as collateral agent (in such capacity, the “Collateral Agent,” as more fully set forth in Section 1.01).
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF NANOSTRING TECHNOLOGIES, INC.NanoString Technologies Inc • November 6th, 2023 • Biological products, (no disgnostic substances) • New York
FOR VALUE RECEIVED, the undersigned, NanoString Technologies, Inc., a Delaware corporation (together with its successors and assigns, the “Company”), hereby certifies that [_______] or any transferee, assignee or other subsequent holder hereof (the “Holder”) is entitled to subscribe for and purchase, at the Exercise Price per share, the Warrant Share Number of duly authorized, validly issued, fully paid and non-assessable shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). This Warrant is issued pursuant to that certain Exchange Agreement, dated as of November 6, 2023, by and among the Company, Braidwell Partners Master Fund LP and Deerfield Partners, L.P. (as may be amended, restated, supplemented or otherwise modified from time to time in accordance with the terms thereof, the “Exchange Agreement”). The Common Shares (as defined below) issuable hereunder (the “Warrant Shares”) are entitled to the benefits of the Registration Rights Agreement (as de
